Successful Alectinib Treatment for Carcinoma of Unknown Primary with EML4-ALK Fusion Gene: A Case Report

Gene alteration in anaplastic lymphoma kinase (ALK) is rare, and the efficacy of ALK inhibitors in the treatment of carcinoma of unknown primary (CUP) with ALK alteration remains unclear. The patient was a 56-year-old woman who presented with cervical lymph node swelling. Computed tomography reveale...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiyama, Keiji, Izumika, Ai, Iwakoshi, Akari, Nishibori, Riko, Sato, Mariko, Shiraishi, Kazuhiro, Hattori, Hiroyoshi, Nishimura, Rieko, Kitagawa, Chiyoe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161847/
https://www.ncbi.nlm.nih.gov/pubmed/34064158
http://dx.doi.org/10.3390/curroncol28030180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161847/
https://www.ncbi.nlm.nih.gov/pubmed/34064158
http://dx.doi.org/10.3390/curroncol28030180

Ejemplares similares